Want to see JP:6523 full AI Analyst Report?

PHC Holdings Corp. (6523) Price & Analysis

1 Followers

6523 Stock Chart & Stats

¥1112.00

¥4.00(0.41%)

At close: Jan 08 4:00 PM EST

¥1112.00

¥4.00(0.41%)

Day’s Range― - ―

52-Week Range¥916.00 - ¥1,189.00

Previous CloseN/A

Volume174.10K

Average Volume (3M)164.09K

Market Cap

¥140.94B

Enterprise Value¥348.64K

Total Cash (Recent Filing)¥39.82B

Total Debt (Recent Filing)¥234.56B

Price to Earnings (P/E)288.6

Beta0.49

Next Earnings

Aug 06, 2026

EPS Estimate

21.19

Next Dividend Ex-DateN/A

Dividend Yield3.81%

Share Statistics

EPS (TTM)3.85

Shares Outstanding127,320,915

10 Day Avg. Volume194,380

30 Day Avg. Volume164,093

Financial Highlights & Ratios

PEG Ratio-2.94

Price to Book (P/B)0.85

Price to Sales (P/S)0.38

P/FCF Ratio4.13

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)128.6

Revenue Forecast (FY)¥366.43B

Bulls Say, Bears Say

Bulls Say

Recurring Consumables And Service RevenuePHC's installed base model—selling diagnostic instruments plus consumables and services—creates durable, predictable revenue streams. Consumables drive repeat purchases and higher lifetime customer value, smoothing top-line volatility and supporting long-term cash conversion and service margins.

Improving Revenue Growth With Stable Gross MarginsA sustained revenue pick-up and consistent mid‑40% gross margins indicate underlying demand and pricing power in diagnostics and life‑science products. Stable gross margins across cycles support operating leverage potential if fixed costs are controlled, aiding durable profitability recovery prospects.

Consistent Positive Operating And Free Cash FlowPositive and improving operating cash flow, and free cash flow that stayed positive even in loss years, demonstrate strong cash conversion. This cash generation underpins debt servicing, dividend capacity, and reinvestment for product development and service networks over the medium term.

Bears Say

Highly Volatile ProfitabilityLarge swings from multi‑year losses to a one‑year profit then near break‑even reflect inconsistent operating performance. Such volatility complicates planning, weakens investor confidence, and raises execution risk for sustaining margin improvements absent clear structural drivers of stable earnings.

Elevated Leverage Despite ImprovementAlthough leverage has declined, a debt-to-equity near 1.45x still represents meaningful financial obligations. Elevated debt increases vulnerability to cash flow shocks, limits strategic flexibility for M&A or capex, and raises refinancing risk if earnings or cash generation soften.

Operating Cash Flow Covers Modest Share Of DebtOCF covering only ~20–25% of total debt implies the company must rely on continued strong cash generation or refinancing to reduce leverage. This constrains free cash available for growth investments and raises risk if market conditions or margins deteriorate over the medium term.

PHC Holdings Corp. News

Is 2GY a Buy, Before Earnings?

PHC Holdings Corp. (2GY) is scheduled to report 4th quarter earnings on 05/13/2026. Regarding Q4 estimates, Wall Street...

3M ago

2GY Upcoming Earnings Report: What to Expect?

PHC Holdings Corp. (2GY) is scheduled to report 2nd quarter earnings on 11/12/2025. Regarding Q2 estimates, Wall Street...

9M ago

6523 FAQ

What was PHC Holdings Corp.’s price range in the past 12 months?

PHC Holdings Corp. lowest stock price was ¥916.00 and its highest was ¥1189.00 in the past 12 months.

What is PHC Holdings Corp.’s market cap?

PHC Holdings Corp.’s market cap is ¥140.94B.

When is PHC Holdings Corp.’s upcoming earnings report date?

PHC Holdings Corp.’s upcoming earnings report date is Aug 06, 2026 which is in 8 days.

How were PHC Holdings Corp.’s earnings last quarter?

PHC Holdings Corp. released its earnings results on May 13, 2026. The company reported -¥1.6 earnings per share for the quarter, missing the consensus estimate of ¥15.83 by -¥17.43.

Is PHC Holdings Corp. overvalued?

According to Wall Street analysts PHC Holdings Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does PHC Holdings Corp. pay dividends?

PHC Holdings Corp. pays a Semiannually dividend of ¥21 which represents an annual dividend yield of 3.81%. See more information on PHC Holdings Corp. dividends here

What is PHC Holdings Corp.’s EPS estimate?

PHC Holdings Corp.’s EPS estimate is 21.19.

How many shares outstanding does PHC Holdings Corp. have?

PHC Holdings Corp. has 127,320,915 shares outstanding.

What happened to PHC Holdings Corp.’s price movement after its last earnings report?

PHC Holdings Corp. reported an EPS of -¥1.6 in its last earnings report, missing expectations of ¥15.83. Following the earnings report the stock price went down -1.957%.

Which hedge fund is a major shareholder of PHC Holdings Corp.?

Currently, no hedge funds are holding shares in JP:6523

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

PHC Holdings Corp.

PHC Holdings Corporation, through its network of subsidiaries, specializes in the innovation, production, and sale of medical instruments, advanced healthcare technology solutions, and life science merchandise. The company's product line includes blood glucose monitoring systems and a variety of other diagnostic and analytical tools, alongside sophisticated data integration platforms. It also delivers end-to-end anatomical pathology solutions, featuring specialized equipment, microscope slides, and diverse staining reagents. In the life sciences sector, PHC provides essential equipment and support services for sample preservation and cell culture. Furthermore, the company develops and deploys healthcare IT products, focusing on medical information systems designed for clinics and pharmacies dealing with health insurance. Its operations also extend to clinical testing, the manufacturing of diagnostic reagents, and providing support for pharmaceutical development. Established in 2014 and based in Tokyo, Japan, the company was formerly recognized as Panasonic Healthcare Holdings Co., Ltd. before officially changing its name to PHC Holdings Corporation in April 2018.